TIDMMHC

MyHealthChecked PLC

24 August 2021

MyHealthChecked plc

( " MyHealthChecked " or " the Company " )

Statement re. DHSC press release

MyHealthChecked welcomes further scrutiny of private testing companies

MyHealthChecked Plc (AIM: MHC), the consumer home-testing healthcare company, welcomes the announcement yesterday from the Department of Health and Social Care ("DHSC") that private COVID-19 testing companies will be removed from the GOV.UK list if they advertise misleading prices. 82 providers, making up around 18% of companies listed, have been identified as displaying lower prices on GOV.UK than are available on their website at the point of checkout.

MyHealthChecked welcomes a greater degree of Government scrutiny of private testing companies included on the UK Government list of approved providers of COVID-19 testing service for travel. Not only does MyHealthChecked provide clear, transparent and market competitive pricing for compliant testing for international travel tests, but also ensures a high standard of service and robust laboratory capacity planning methods to ensure customer needs are met.

Penny McCormick, Chief Executive Officer of MyHealthChecked Plc, said:

"This is very good news for the public as it will only improve the calibre of COVID-19 testing services available, and ensure pricing is transparent whilst driving an improvement in quality of service from those approved companies included on the Government list. At MyHealthChecked we have always been clear on pricing. We have made pricing information simple, the nasal swab process is simple and our customer care is second to none, with tens of thousands of satisfied customers as a result of our service.

"Sadly, we hear reports of other testing companies on the Government list also falling short when it comes to maintaining high standards across other aspects of their service and we welcome the Health Secretary's call for the competition watchdog to investigate concerns about inadequate service.

"We agree with the Government that only the most compliant, reliable and efficient testing service providers should be on that list and we take great pride that we can fulfil our obligations for laboratory capacity, achievement of turnaround times at our labs, and clear pricing structures across the portfolio."

MyHealthChecked's services have been included as one of the suppliers on the Government list with "Fit to Fly", "Test to Release" and "Days 2 and 8" testing, and the Company has established a key commercial partnership with Boots UK Limited ("Boots") . The MyHealthChecked COVID-19 testing service is available via www.boots.com and across over 500 Boots stores in Great Britain.

The MyHealthChecked(TM) COVID-19 at-home nasal swab kit and PCR laboratory testing service utilises the Company's own laboratory in Manchester, together with its partner laboratory provided by Yourgene Health plc. The laboratories used as part of the MyHealthChecked(TM) COVID-19 testing service all deliver a proficient and high-quality service.

The full DHSC announcement can be seen here:

https://www.gov.uk/government/news/82-testing-providers-to-be-issued-warnings-over-misleading-prices

For further information contact:

 
 MyHealthChecked plc                                                     www.myhealthchecked.com 
 P enny McCormick , Chief Executive                                              via Walbrook PR 
  Officer 
 Gareth Davies, Chief Financial and 
  Operations Officer 
 
 SPARK Advisory Partners Limited (NOMAD)                                Tel: +44 (0)20 3368 3550 
 Neil Baldwin 
 
 Oberon Capital Ltd (Broker)                                            Tel: +44 (0)203 179 5344 
 Mike Seabrook                                                mikeseabrook@oberoninvestments.com 
 
 Walbrook PR Ltd (Media &          Tel: +44 (0)20 7933 8780 or myhealthcheckedplc@walbrookpr.com 
  IR) 
 Paul McManus / Alice Woodings                             Mob: +44(0)7980 541 893 / +44 (0)7407 
                                                                                         804 654 
 
 

About MyHealthChecked PLC ( www.myhealthcheckedplc.com )

MyHealthChecked PLC, based in Cardiff, is an AIM-quoted pioneering UK healthcare company focused on a range of at-home healthcare and wellness tests.

MyHealthChecked is the umbrella brand of a range of at-home DNA and RNA tests, now in development following the acquisition of The Genome Store in November 2020. The tests will be made available online, and would be viable for over the counter purchase.

The MyHealthChecked portfolio has been identified as part of a change in mindset as customers become more familiar with the concept of accessible healthcare in the growing at home testing kit market with a focus on accessibility at the right price, led by UK-based experts.

About RNS Reach announcements

RNS Reach is an investor communication service aimed at assisting listed and unlisted (including AIM quoted) companies to distribute media only / non-regulatory news releases such as marketing messages, corporate and product information into the public domain. An RNS Regulatory announcement is required to be notified under the AIM Rules for Companies.

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word "Reach" in the source column of the News Explorer pages of London Stock Exchange's website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NRAUOUARAVUWUUR

(END) Dow Jones Newswires

August 24, 2021 02:00 ET (06:00 GMT)

Concepta (LSE:CPT)
Gráfica de Acción Histórica
De Dic 2021 a Ene 2022 Haga Click aquí para más Gráficas Concepta.
Concepta (LSE:CPT)
Gráfica de Acción Histórica
De Ene 2021 a Ene 2022 Haga Click aquí para más Gráficas Concepta.